| Dr Leslie A Spry, MD | |
|
7441 O St, Ste 304, Lincoln, NE 68510-2468 | |
| (402) 484-5600 | |
| (402) 484-5630 |
| Full Name | Dr Leslie A Spry |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 47 Years |
| Location | 7441 O St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679522528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | A14441 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Center Of Lincoln - Home | Lincoln, NE | Dialysis facility |
| York General Hospital | York, NE | Hospital |
| Bryan Medical Center | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lincoln Nephrology And Hypertension Pc | 7315931771 | 12 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.
Using a mouse model, researchers have shown that elevated levels of a small protein known as interleukin 7 (IL-7) plays a central role in regulating the production of a type of white blood cell that is required for effective immune responses.
Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company's stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.
› Verified 1 days ago
| Entity Name | Lincoln Nephrology & Hypertension Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528077880 PECOS PAC ID: 7315931771 Enrollment ID: O20040409000380 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.
Using a mouse model, researchers have shown that elevated levels of a small protein known as interleukin 7 (IL-7) plays a central role in regulating the production of a type of white blood cell that is required for effective immune responses.
Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company's stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leslie A Spry, MD 7441 O St, Ste. 304, Lincoln, NE 68510-2468 Ph: (402) 484-5600 | Dr Leslie A Spry, MD 7441 O St, Ste 304, Lincoln, NE 68510-2468 Ph: (402) 484-5600 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.
Using a mouse model, researchers have shown that elevated levels of a small protein known as interleukin 7 (IL-7) plays a central role in regulating the production of a type of white blood cell that is required for effective immune responses.
Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company's stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.
› Verified 1 days ago
Ted M Triggs, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 | |
Joseph L Kummer, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1600 S 48th St, Suite 600, Lincoln, NE 68506 Phone: 402-483-3333 Fax: 402-483-3297 | |
Brenda Kay Bell, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1919 S 40th, Ste 207, Lincoln, NE 68506 Phone: 402-489-3383 Fax: 402-489-3789 | |
Scott Allen Heasty, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-4780 Fax: 402-481-5377 | |
Scott Charles Rasmussen, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3901 Pine Lake Rd, Suite 220, Lincoln, NE 68516 Phone: 402-421-3240 Fax: 402-423-0739 | |
Jeffrey E Jarrett, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St, Suite 800, Lincoln, NE 68506 Phone: 402-483-8600 Fax: 402-483-8689 | |
Tracy L Slocum Farritor, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 |